Julie Kilgore

Oct 30, 2024 | corporatecomplianceinsights.com | L. Hannah Ji-Otto |David Chen |Julie Kilgore

De-identification is a valuable tool for protecting consumer privacy, but the process requires diligent compliance with multiple state and federal standards. L. Hannah Ji-Otto and Julie A. Kilgore, both of Baker Donelson, and legal adviser David Chen explore the various regulatory perspectives on data de-identification and their implications for businesses operating in the United States.

Jul 2, 2024 | jdsupra.com | Julie Kilgore

The United States Department of Health and Human Services (HHS) has now established disincentives for certain health care providers if found by the Office of Inspector General (OIG) to have committed information blocking under the 21st Century Cures Act (Cures Act). In June 2023, the OIG published a Final Rule establishing penalties for information blocking actors other than health care providers.

Apr 24, 2024 | jdsupra.com | Julie Kilgore

The Office of the National Coordinator for Health Information Technology (ONC) released the anticipated Common Agreement Version 2.0 on April 22, 2024. Since 2016, the ONC has been working to implement the requirements of the 21st Century Cures Act (Cures Act), and this release marks another milestone on the journey to complete those directives.

Jan 4, 2024 | jdsupra.com | Julie Kilgore

The value of data is on the minds of all industries right now, and health care is no different. The increased attention comes with the very significant shift in thinking, advanced by the attention to the advent of artificial intelligence. As an acknowledgment of the complexities, the Joint Commission established the Responsible Use of Health Data™ (RUHD) program, which became available to eligible hospitals (RUHD Certification) on January 1.

Oct 3, 2023 | jdsupra.com | Alisa Chestler |Julie Kilgore

Are you a health care provider, business associate, or other entity subject to the requirements of the Health Insurance Portability and Accountability Act (HIPAA) regarding the use and disclosure of protected health information (PHI)? Do you know whether any of the web pages on your websites or mobile apps use third-party tracking technologies? Do you know what data you’re disclosing to third-party tracking technology companies and how that data is being used by those companies?